-
Founded in:
2000-11-13 -
Country:
China -
Address:
No. 3809 Huangshan Avenue, Bengbu City -
Tax NO.:
91340300723348633W -
Registered Funds:
98.5 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetylsalicylic acid |
This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects
More
This product can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects |
50-78-2 | 35 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nateglinide |
Nateglinide is an amino acid derivative and an oral antidiabetic drug used to treat patients with type 2 diabetes. The action of nateglinide depends on the function of pancreatic beta cells. Nateglinide binds to the ATP-sensitive K channel receptor on the beta cell membrane and closes it, causing cell depolarization, calcium channel opening, calcium influx, stimulating insulin secretion, and lowering blood sugar. The insulin secretion-promoting effect of nateglinide depends on the glucose level. When the glucose level is low, the insulin secretion is weakened. Nateglinide has a high degree of tissue selectivity and has a low affinity for cardiac muscle and skeletal muscle.
More
Nateglinide is an amino acid derivative and an oral antidiabetic drug used to treat patients with type 2 diabetes. The action of nateglinide depends on the function of pancreatic beta cells. Nateglinide binds to the ATP-sensitive K channel receptor on the beta cell membrane and closes it, causing cell depolarization, calcium channel opening, calcium influx, stimulating insulin secretion, and lowering blood sugar. The insulin secretion-promoting effect of nateglinide depends on the glucose level. When the glucose level is low, the insulin secretion is weakened. Nateglinide has a high degree of tissue selectivity and has a low affinity for cardiac muscle and skeletal muscle. |
105816-04-4 | 24 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nateglinide |
Nateglinide is an amino acid derivative and an oral antidiabetic drug used to treat patients with type 2 diabetes. Nateglinide binds to the ATP-sensitive K channel receptor on the β cell membrane and closes it, causing cell depolarization, calcium channel opening, calcium influx, stimulating insulin secretion, and lowering blood sugar. Nateglinide's insulin secretion-promoting effect depends on glucose levels. When glucose levels are low, insulin secretion is weakened. Nateglinide has a high degree of tissue selectivity and has low affinity for cardiac and skeletal muscles.
More
Nateglinide is an amino acid derivative and an oral antidiabetic drug used to treat patients with type 2 diabetes. Nateglinide binds to the ATP-sensitive K channel receptor on the β cell membrane and closes it, causing cell depolarization, calcium channel opening, calcium influx, stimulating insulin secretion, and lowering blood sugar. Nateglinide's insulin secretion-promoting effect depends on glucose levels. When glucose levels are low, insulin secretion is weakened. Nateglinide has a high degree of tissue selectivity and has low affinity for cardiac and skeletal muscles. |
105816-04-4 | 24 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| D-Glucurone |
After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves.
More
After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves. |
32449-92-6 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| D-Glucurone |
After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves.
More
After entering the body, this product can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves. |
32449-92-6 | 6 |